NCE-1 Intelligence & Market Opportunity

Mounjaro

Tirzepatide

Antidiabetic

Subcutaneous Solution

Mounjaro (tirzepatide) settled a long-running debate about whether adding GIP agonism to GLP-1 would help or hurt in type 2 diabetes.

Tirzepatide engages two incretin pathways at once, producing greater HbA1c and weight reduction than GLP-1 agonism alone in head-to-head trials. The once-weekly subcutaneous injection improves glycemic control in adults with type 2 diabetes alongside diet and exercise.

Tirzepatide was subsequently approved as Zepbound for chronic weight management and obstructive sleep apnea, making it one of the highest-value assets in the industry. Supply constraints, compounding disputes, and outcomes data have defined its commercial trajectory.

Approval Date

13-May-22

NCE-1 Date

13-May-26

NCE Date

13-May-27

Commercial snapshot

Market performance & projections

Revenue ($M)

22,965

CAGR (%)

19.62%

Projected sales, 2026–2032 ($M)

Analyst projection, $M per year

2026

35,002

2027

39,798

2028

43,616

2029

47,026

2030

49,861

2031

52,602

2032

54,903

Molecule profile

Details & specifications

Molecule

Tirzepatide

Innovator

ELI LILLY AND COMPANY

Dosage Form

Subcutaneous Solution

Strength

60 mg/2.4 mL (25 mg/mL), 40 mg/2.4 mL (16.7 mg/mL), 5 mg/0.5 mL (5 mg/0.5 mL), 20 mg/2.4 mL (8.33 mg/mL), 15 mg/0.5 mL (15 mg/0.5 mL), 10 mg/0.5 mL (10 mg/0.5 mL), 10 mg/2.4 mL (4.17 mg/mL), 50 mg/2.4 mL (20.8 mg/mL), 7.5 mg/0.5 mL (7.5 mg/0.5 mL), 30 mg/2.4 mL (12.5 mg/mL), 2.5 mg/0.5 mL (2.5 mg/0.5 mL), 12.5 mg/0.5 mL (12.5 mg/0.5 mL)

Therapeutic Category

Antidiabetic

Usage

To improve blood sugar control in diabetes, in addition to diet and exercise

Good to know

Frequently asked questions

Ready to act on this opportunity?

Talk to Spring Bio Solution about sourcing, licensing, and filing support for this molecule.

Why Spring Bio Solution

Supported 1000+ clinical trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions

Global sourcing capability across US, EU, South Africa, Canada, Japan, Australia, New Zealand, Southeast Asia, and other key markets